Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compounds
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 March 2026.
All research outputs
#11,170,533
of 34,217,933 outputs
Outputs from Journal of Psychopharmacology
#1,216
of 2,544 outputs
Outputs of similar age
#92,008
of 372,224 outputs
Outputs of similar age from Journal of Psychopharmacology
#17
of 33 outputs
Altmetric has tracked 34,217,933 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 2,544 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 31.7. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 372,224 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
